Are you Dr. Wruble?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 21 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8000 Wolf River Blvd
Suite 200
Germantown, TN 38138Phone+1 901-747-3630Fax+1 901-747-4039
Summary
- Dr. Lawrence Wruble, MD is a gastroenterologist in Germantown, Tennessee. He is currently licensed to practice medicine in Tennessee. He is affiliated with Methodist Le Bonheur Germantown Hospital, Baptist Memorial Hospital for Women, and Baptist Memorial Hospital - Memphis.
Education & Training
- University of Miami/Jackson Health SystemFellowship, Gastroenterology, 1961 - 1963
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1959 - 1961
- Philadelphia General HospitalInternship, Transitional Year, 1958 - 1959
- University of Tennessee Health Science Center College of MedicineClass of 1958
Certifications & Licensure
- TN State Medical License 1958 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow (FACG) American College of Gastroenterology
Publications & Presentations
PubMed
- 466 citationsPrognostic factors in colorectal carcinomas arising in adenomas: Implications for lesions removed by endoscopic polypectomyRodger C. Haggitt, Raymond E. Glotzbach, Edward E. Soffer, L. D. Wruble
Gastroenterology. 1985-08-01 - 219 citationsInfliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic ResectionMiguel Regueiro, Brian G. Feagan, Bin Zou, Jewel Johanns, Marion Blank
Gastroenterology. 2016-06-01 - 83 citationsRepifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: A randomized, double-blind, placebo-controlled, dose-escalation trialWilliam J. Sandborn, Bruce E. Sands, Douglas C. Wolf, John F. Valentine, Michael Safdi
Alimentary Pharmacology & Therapeutics. 2003-06-01
Professional Memberships
- Fellow